To address the necessity of
Shp2 for maintaining corneal epithelial homeostasis,
K14-rtTA;tetO-Cre;Shp2flo x/flo x triple–transgenic mice were subject to central corneal epithelial abrasion and then were treated with Dox (
Shp2cko ) or with regular chow (control) for 8 days as shown in
Figure 6A. In a naïve cornea, Cre recombinase effectively knocked out
Shp2 alleles from the basal epithelial cells upon Dox treatment (
Supplementary Fig. S5C, arrows). This resulted in the loss of basal lamellar structure (compare
Figs. 6D and
6B, arrowheads), but did not crushed down stratified epithelium. In wounded eye, the initial re-epithelialization to cover the 2-mm diameter wound area behaved no differently between +Dox and −Dox as judged by the corneal epithelial fluorescein staining at 24 hours after wound healing (data not shown). This result suggested that Shp2 was not required for cell migration during early phase wound closure. Therefore, we did not attempt to compare the migrating leading edge within 6 to 24 hours after the wound. However, when examining if the epithelium could restore seven to eight layers and display typical basal lamellar structure 8 days after epithelial abrasion during wound healing, we noticed that these only happened when
Shp2 remained intact in the absence of Dox (
Fig. 6C, arrowheads). In contrast, epithelial restratification was compromised (
Fig. 6E) when
Shp2 was ablated in the presence of Dox (
Supplementary Fig. S5C). Concomitantly, laminin-β1 expression was drastically reduced in the unwounded eye (compare
Supplementary Figs. S5G and S5E) and completely diminished during wound healing (
Supplementary Fig. S5H) when
Shp2 was ablated, while laminin-β1 expression was upregulated during epithelial restratification (
Supplementary Fig. S5F) when Shp2 was expressed (
Supplementary Fig. S5B). Moreover, as shown in
Supplementary Figure 6E, 80.0 ± 5.3% (+Dox) versus 82.7 ± 3.5% (−Dox) of basal cells in the unwounded eye and 76.3 ± 3.4% (+Dox) versus 78.5 ± 2.1% (−Dox) of basal cells in the wounded eye were PCNA-positive, suggesting that proliferative activity was not altered when
Shp2 was ablated in the unwounded cornea (compare
Supplementary Figs. S6C and S6A) and in corneal restratification during wound healing (compare
Supplementary Figs. S6D and S6B). On the other hand, as revealed in Figure 8E, the percentage of ΔNp63-positive cells was reduced approximately 3.3-fold (from 63.9 ± 4.4% to 19.4 ± 4.1%) when
Shp2 was ablated in the unwounded cornea (compare
Supplementary Figs. S6C′ and S6A′). More interestingly, we found that nearly half (48.7 ± 4.8%) of the re-epithelialized epithelial cells expressed ΔNp63 (
Supplementary Fig. S6B′), but only 3.6 ± 2.5% of those were ΔNp63-positive when
Shp2 was ablated during wound healing (
Supplementary Fig. S6D′). Taken together, these data argued that
Shp2 deficiency caused downregulation of ΔNp63 and the impairment of stratification during corneal epithelial wound healing.